OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer’s Disease
Lei Wang, Tian‐Yu Sun, Zhenqi Wang, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 17, pp. 3226-3248
Closed Access | Times Cited: 9

Showing 9 citing articles:

Role of histone deacetylases and their inhibitors in neurological diseases
Liying Zhang, Sen-Yu Zhang, Ri Wen, et al.
Pharmacological Research (2024), pp. 107410-107410
Open Access | Times Cited: 17

Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 16

New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 16

Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
Zhicheng Gu, Shuxian Lin, Junhui Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116571-116571
Closed Access | Times Cited: 6

Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy
Osama M. Soltan, Kamal S. Abdelrahman, Amr K. A. Bass, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107651-107651
Closed Access | Times Cited: 6

Machine learning in Alzheimer’s disease drug discovery and target identification
Chaofan Geng, Zhibin Wang, Yi Tang
Ageing Research Reviews (2023) Vol. 93, pp. 102172-102172
Closed Access | Times Cited: 11

Dual inhibitors of butyrylcholinesterase and histone deacetylase 6 for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation
Bingbing Lv, Zhenqi Wang, Qinjie Wang, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 127, pp. 118219-118219
Closed Access

Therapeutic Potential of Dual HDAC6/SIRT2 Inhibition in Alzheimer’s Disease
Xingyu Wang, Cunjiang Li, Lei Chen, et al.
European Journal of Medicinal Chemistry (2025) Vol. 294, pp. 117733-117733
Closed Access

Page 1

Scroll to top